3-Phenoxy-1,2-propanediol is a weak aquaporin 4 inhibitor

**Background**

Aquaporins (AQPs) are a family of integral membrane proteins that serve as channels for the transport of water and other small uncharged solutes across cell membranes. Among these, aquaporin 4 (AQP4) is the most abundant water channel in the central nervous system, where it is primarily expressed in astrocyte foot processes. AQP4 plays a critical role in maintaining water homeostasis, regulating brain volume, and facilitating the glymphatic system’s clearance of metabolic waste. Dysregulation of AQP4 has been implicated in various pathological conditions, including cerebral edema, neuromyelitis optica, and neurodegenerative diseases. Consequently, the identification of small-molecule inhibitors that can modulate AQP4 activity is of significant research interest for developing therapeutic strategies to manage brain water homeostasis. In this context, we will introduce a weak aquaporin 4 inhibitor – 3-Phenoxy-1,2-propanediol.

**Definition**

3-Phenoxy-1,2-propanediol is a small molecule compound that acts as a weak inhibitor of aquaporin 4 (AQP4). According to the 3-Phenoxy-1,2-propanediol description, it serves as an important intermediate for the synthesis of various pharmaceuticals.

**Biological Activity**

The 3-Phenoxy-1,2-propanediol biological activity has been evaluated through both in vitro and in silico methodologies to determine its interaction with water channels. With a molecular weight of 168.19 and a 3-Phenoxy-1,2-propanediol formula of C9H12O3, this compound exhibits a structure that allows it to interact with the AQP4 pore, although its inhibitory potency is characterized as weak. Beyond its role as an AQP4 inhibitor, the compound is a valuable building block in organic synthesis. Research has demonstrated that 3-phenoxy-1,2-propanediol can be efficiently resolved using immobilized lipase on amphiphilic comb polymer modified TiO2, highlighting its utility in enzymatic resolution and pharmaceutical intermediate production. In conclusion, 3-Phenoxy-1,2-propanediol is a weak AQP4 inhibitor and a versatile pharmaceutical intermediate.

Keywords

3-Phenoxy-1,2-propanediol, 538-43-2, Aquaporin, AQP, AQP4 Inhibitor, intermediate for pharmaceuticals, Inhibitor, inhibitor, inhibit

References

[1] Huber VJ, et al. Identification of aquaporin 4 inhibitors using in vitro and in silico methods. Bioorg Med Chem. 2009 Jan 1;17(1):411-7.
[2] Bin Wang, et al. Efficient resolution of 3-phenoxy-1,2-propanediol by immobilized lipase on amphiphilic comb polymer modified TiO2. Journal of Molecular Catalysis B: Enzymatic. Volume 106, August 2014, Pages 105-110.